JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 43(2009) N 3 p. 394-402;
V.I. Loginov1, D.S. Khodyrev1, I.V. Pronina1,2, T.P. Kazubskaya3, V.D. Ermilova3, R.F. Gar\'kavtseva3, E.A. Braga1

Methylation of the RASSF1 Apromoter region and the allelic imbalance frequencies in chromosome 3 critical regions correlate with progression of clear cell renal carcinoma

1State Research Center "GosNIIGenetika", Moscow, 117545, Russia
2Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia
3Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, 115478, Russia
Received - 2008-08-22; Accepted - 2008-10-20

The short arm of chromosome 3 (3p) contains several critical regions that have increased frequencies of allelic deletions and harbor a set of tumor suppressor genes. In particular, the range of functions performed by RASSF1A (LUCA region, 3p21.31) includes those potentially associated with carcinogenesis. Among 3p genes, RASSF1A has the highest methylation frequency in epithelial tumors of various locations. For the first time, two different methods (methylation-specific PCR and methylation-sensitive restriction analysis) independently showed that the methylation level of the CpG island in the RASSF1A promoter region significantly correlated with grade and clinical stage of clear cell renal cell carcinoma (RCC). An analysis of 23 3p polymorphic markers in a representative set of 80 RCC cases characterized clinically and histologically revealed that RCC progression significantly correlated with the frequency of allelic imbalances in some critical regions of 3p (LUCA and AP20), but not in 3p as a whole. These data suggest that RCC progression is associated with the methylation of the RASSF1A promoter and, possibly, with structural and functional alterations in other 3p genes. In addition, significant correlation between RASSF1A methylation and allelic losses at the nearby polymorphic marker locus suggests the "two hit" model for the inactivation of this tumor suppressor gene in RCC.

chromosome 3, RASSF1A, promoter region, methylation, allelic alteration, polymorphic marker, methylation specific PCR, methylation sensitive restriction endonuclease, clear cell renal cell carcinoma, cancer progression



JMB-FOOTER RAS-JOURNALS